Velan Capital Investment Management LP 13D and 13G filings for Jasper Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-02-27 4:05 pm Unchanged | 2023-02-16 | 13D | Jasper Therapeutics, Inc. JSPR | Velan Capital Investment Management LP | 1,121,904 10.200% | 0 (Unchanged) | Filing |
2023-01-27 4:56 pm Purchase | 2023-01-25 | 13G | Jasper Therapeutics, Inc. JSPR | Velan Capital Investment Management LP | 1,121,904 10.200% | 1,121,904 (New Position) | Filing |